Follow this preprint

Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

Natalie J. Miller, Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Davila, Sylvia Lee, Keith D. Eaton, Renato G. Martins, Cristina Rodriguez, Heather A. Wakelee, Sukhmani K. Padda, Eric Q. Konnick, Alex Camai, Tatyana Pisarenko, Viswam S. Nair, A. McGarry Houghton, Shin-Heng Chiou, Diane Tseng
doi: https://doi.org/10.1101/2025.03.10.25323586
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2025.03.10.25323586
History 
  • March 13, 2025.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Natalie J. Miller1,
  2. Christina S. Baik1,
  3. Joel W. Neal2,
  4. Fangdi Sun2,
  5. Rafael Santana-Davila3,
  6. Sylvia Lee3,
  7. Keith D. Eaton3,
  8. Renato G. Martins4,
  9. Cristina P. Rodriguez3,
  10. Heather A. Wakelee2,
  11. Sukhmani K. Padda5,
  12. Eric Q. Konnick3,
  13. Alex E. Camai6,
  14. Tatyana Pisarenko6,
  15. Viswam S. Nair3,
  16. A. McGarry Houghton3,
  17. Shin-Heng Chiou7 and
  18. Diane Tseng3,8 (ditseng{at}uw.edu)
  1. 1 University of Washington/Fred Hutch Cancer Center;
  2. 2 Stanford University;
  3. 3 University of Washington/Fred Hutchinson Cancer Center;
  4. 4 Virginia Commonwealth University;
  5. 5 Fox Chase Cancer Center/Temple Health;
  6. 6 Fred Hutchinson Cancer Center;
  7. 7 Rutgers Cancer Institute
  1. ↵* Corresponding author; email: ditseng{at}uw.edu
Back to top
Posted March 13, 2025.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
Natalie J. Miller, Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Davila, Sylvia Lee, Keith D. Eaton, Renato G. Martins, Cristina Rodriguez, Heather A. Wakelee, Sukhmani K. Padda, Eric Q. Konnick, Alex Camai, Tatyana Pisarenko, Viswam S. Nair, A. McGarry Houghton, Shin-Heng Chiou, Diane Tseng
medRxiv 2025.03.10.25323586; doi: https://doi.org/10.1101/2025.03.10.25323586
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.